News
Australia's CSL Ltd said it's evaluating whether its drugs used in surgery would be exempted from 125% tariffs China imposed ...
Explore the breakthroughs in liver organoid research. Discover how cryopreserved cells reshape studies on liver regeneration.
InVitria, a leading developer of recombinant, chemically defined components for biomanufacturing, has announced the launch of Optibumin® 25, the first and only recombinant human serum albumin (rHSA) ...
Explore the impact of 3D models in drug discovery and how they enhance predictive insights in pre-clinical research.
Equillium, Inc. , a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today ...
NEW YORK] China has asked some of its state-owned drugmakers to study how they can reduce reliance on the US for pharmaceutical products and raw materials, sources familiar with the matter said, as ...
TNX-1700 is in preclinical development for gastric and colorectal cancers ...
If there's a disease that seems to run in your family, if you've had a negative reaction to a drug or wondered why a standard ...
Despite the market punishing Grifols, we believe that this presents a buying opportunity. Click here for our investment ...
A new study published in the journal of Renal Failure showed that patients with chronic obstructive pulmonary disease (COPD) ...
China can drop other American commodities even more easily. In March the country bought no American wheat or liquefied ...
Roivant Sciences secures $5.2B for advancing late-stage drugs like IMVT-1402 & brepocitinib. Click here to read an analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results